EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements

Sneha Gupta, Sumeet Jha, Supriya Rani, Pinky Arora, Shubham Kumar iD

ChemistryOpen · 2024-11 · 13 (11)

DOI: 10.1002/open.202400147 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemistryOpen, online erschienen am 09.09.2024. Verfasst von Sneha Gupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road, Phagwara, Punjab, 144411, India. Hauptthemen laut MEDLINE: Thiazolidinediones. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

2,4‐Thiazolidinedione derivatives represent nitrogen‐containing heterocyclic compounds utilized in type 2 diabetes mellitus management. Recent advances in medicinal chemistry have unveiled diverse therapeutic potentials and structural modifications of these derivatives. This review delves into novel TZD derivatives, encompassing their synthesis, structure‐activity relationships, and pharmacokinetic profiles. Various therapeutic potentials of TZDs are explored, including anticancer, antimicrobial, anti‐inflammatory, antioxidant, anticonvulsant, antihyperlipidemic, anticorrosive, and antitubercular activities. Additionally, it addresses mitigating side effects associated with marketed TZD derivatives such as weight gain, oedema, fractures, and congestive heart failure in type 2 diabetes mellitus management. The review elaborates on in vivo, in vitro , and ex vivo studies supporting different biological activities, alongside predicting ADME and drug‐likeness properties of TZDs. Computational studies are also integrated to elucidate binding modes and affinities of novel TZD derivatives. Furthermore, a plethora of novel TZD derivatives with varied and enhanced therapeutic potentials are presented, warranting further evaluation of their biological activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiazolidinedionesHumansStructure-Activity RelationshipHypoglycemic AgentsDiabetes Mellitus, Type 2AnimalsAntineoplastic AgentsAntioxidantsAnticonvulsantsAnti-Infective AgentsAnti-Inflammatory Agents

Stichwörter der Autor:innen

2,4-ThiazolidinedioneAnticancerAntimicrobialMechanism of ActionRecent AdvancesReview

Substanzen

Thiazolidinediones2,4-thiazolidinedioneHypoglycemic AgentsAntineoplastic AgentsAntioxidantsAnticonvulsantsAnti-Infective AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road, Phagwara, Punjab, 144411, India.
  • School of bioengineering and biosciences, Lovely Professional University, Jalandhar-Delhi G.T. Road, Phagwara, Punjab, 144411, India.

ORCID-Profile: Shubham Kumar

Zitieren

APA

Gupta, S., Jha, S., Rani, S., Arora, P., & Kumar, S. (2024). Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements. ChemistryOpen, 13(11). https://doi.org/10.1002/open.202400147

Vancouver

Gupta S, Jha S, Rani S, Arora P, Kumar S. Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements. ChemistryOpen. 2024;13(11). doi:10.1002/open.202400147

BibTeX
@article{Gupta2024,
  author = {Gupta, Sneha and Jha, Sumeet and Rani, Supriya and Arora, Pinky and Kumar, Shubham},
  title = {Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements},
  journal = {ChemistryOpen},
  year = {2024},
  volume = {13},
  number = {11},
  doi = {10.1002/open.202400147}
}
Kostenlos starten →